AG
ORIC icon

Algert Global’s Oric Pharmaceuticals ORIC Stock Holding History

Algert Global’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Buy
136,350
+95,840
+237% +$1.09M 0.03% 744
2025
Q4 		$331K Buy
+40,510
New +$466K 0.01% 991
2023
Q4 		– Sell
-13,430
Closed -$81K – 1228
2023
Q3 		$81K Buy
+13,430
New +$110K ﹤0.01% 1044

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Algert Global's ORIC Position: Q1 2026 in Review

Algert Global increased its Oric Pharmaceuticals (ORIC) stake by 237% in Q1 2026, buying an estimated $1.09M and bringing the position to 136,350 shares worth $1.73M. The position accounts for 0.03% of the portfolio, ranked #744.

Algert Global first reported a position in ORIC in Q3 2023 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Algert Global held 136,350 shares of Oric Pharmaceuticals worth $1.73M as of Q1 2026.
  • Algert Global bought 95,840 Oric Pharmaceuticals shares in Q1 2026, an estimated $1.09M.
  • Oric Pharmaceuticals made up 0.03% of Algert Global's portfolio in Q1 2026, its #744 holding.
  • Algert Global first reported a position in Oric Pharmaceuticals in Q3 2023 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.